The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis-Reference-Cited by-同舟云学术

The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis

Published:2018-08-01 Issue:15 Volume:57 Page:2169-2178
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Hasegawa Eriko¹²,Ito Satoshi¹,Takai Chinatsu¹²,Kobayashi Daisuke¹²,Nomura Yumi¹³,Otani Hiroshi¹,Abe Asami¹,Ishikawa Hajime¹,Murasawa Akira¹,Narita Ichiei²,Nakazono Kiyoshi¹

Affiliation:

1. Department of Rheumatology, Niigata Rheumatic Center, Japan

2. Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Japan

3. Department of Orthopedic Surgery, Kagawa University Faculty of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/57/15/57_9885-17/_pdf

Reference18 articles.

1. 1. Manolagas SC, Weistein RS. New developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14: 1061-1066, 1999.

2. 2. Van Staa TP, Leufkens HG, Cooper C. The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13: 777-787, 2002.

3. 3. Buckley L, Guyatt G, Fink HA, et al. 2017 American College of Rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 69: 1095-1110, 2017.

4. 4. Saag KG, Emkey R, Schnitzer TJ, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. N Engl J Med 339: 292-299, 1998.

5. 5. Cohen S, Levy RM, Keller M, et al. Risedronate therapy prevents corticosteroid-induced bone loss. Arthritis Rheum 42: 2309-2318, 1999.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview;International Journal of Molecular Sciences;2023-03-18

2. Identification, Characterization, and the Determination of Process-related Impurities in Minodronic Acid Bulk Drug;Current Pharmaceutical Analysis;2022-03

3. Minodronate in the treatment of osteoporosis;Medicine;2020-10-02

4. Effects of monthly minodronate with or without eldecalcitol addition in osteoporosis patients with rheumatoid arthritis: An 18-month prospective study;Osteoporosis and Sarcopenia;2019-12

5. Prednisolone;Reactions Weekly;2018-09